• Für forschungs- und innovationsfreundliche Rahmenbedingungen
  • Hightech für das ärztliche Labor
  • Früh erkennen - rechtzeitig heilen
  • 1985 kommt der erste HIV-Test auf den Markt

Diagnostica-Markt Europa

EDMA- Market Estimates

EDMA, the European Diagnostic Manufacturers Association represents National Associations and major companies engaged in the research, development, manufacture or distribution of In Vitro Diagnostic (IVD) medical devices in Europe. Through its affiliated National Associations, EDMA represents in total more than 500 companies (or over 700 legal entities) across Europe. The mission of EDMA is to raise awareness of the importance, usefulness and added-value that diagnostic information can provide to healthcare. For this purpose, EDMA cooperates with European institutions, patients groups, trade associations, health professionals and academia to support an appropriate regulatory system, to work towards a realistic economic environment for healthcare in Europe and to be an effective voice in globalisation.

EDMA Consolidated Market Statistics are among the best tools available for understanding the trends in our industry. They are a valuable asset for the IVD industry, and EDMA thanks all companies and countries participating in the European Diagnostic Market Statistics (EDMS) programme.

The accuracy of data is high and major countries have more than 85% of the market covered by companies reporting invoiced sales to an independent auditor. Although IVDs provide critical health information and are crucial for patient outcome, their cost as a percentage of the total healthcare expenditure is low (less than 2%). Short-term investments in IVDs will result in long-term benefits for healthcare.

EDMA Marktschätzung 2010
European IVD Market Estimates 2010

Quelle: EDMA Website

Weitere Daten für unsere Mitglieder «mehr»